Please login to the form below

Not currently logged in
Email:
Password:

France

This page shows the latest France news and features for those working in and with pharma, biotech and healthcare.

MSD hangs ‘for sale’ sign on French facility, shedding 207 staff

MSD hangs ‘for sale’ sign on French facility, shedding 207 staff

in France that will result in 207 job losses across manufacturing and R&D. ... MSD has been gradually reducing its presence in France in recent years, selling its Oise production facility to Amphastar in 2014 and another plant in Saint-Germain-Laprade to

Latest news

More from news
Approximately 25 fully matching, plus 604 partially matching documents found.

Latest Intelligence

  • European biotech: a new generation of leaders emerges European biotech: a new generation of leaders emerges

    potential academic researchers across the continent, with a number of specialist venture capital firms and incubators helping to build success stories in the UK, France, Germany, Belgium and Denmark across a

  • A new EU in the making, what lies ahead for pharma? A new EU in the making, what lies ahead for pharma?

    The HTA file is in a difficult situation at the moment with Germany and France blocking it. ... For smaller companies however, the stakes are higher. If France, Germany and a few other countries want to support innovation and faster market uptake up to

  • Gene therapy market access Q&A Gene therapy market access Q&A

    On the other hand, if you succeed in getting reimbursed, for example, in France, you have much greater reach in that country, as there is one central health insurer, so there

  • Bluebird: on a mission to ‘recode’ the DNA of healthcare Bluebird: on a mission to ‘recode’ the DNA of healthcare

    Bluebird is focusing on Germany, Italy, France and the UK as its initial launch markets, as 90% of Europe’s beta thalassemia patients live in these four countries.

  • The Orkambi row explained The Orkambi row explained

    France agreed to a managed access programme that allowed rapid access tied to later value assessment, and also includes a budget cap of 30m with much lower payment rates beyond that. ... But in February 2018 a disagreement on this deal led Vertex to

More from intelligence
Approximately 5 fully matching, plus 106 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 52 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 67 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...
APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...

Infographics